Clinical Trials Arena December 1, 2023
The app will scan users’ faces and analyse voices to detect and monitor depression in women at different stages of pregnancy.
The Medical and Healthcare products Regulatory Agency (MHRA) has greenlit BlueSkeye AI to begin a clinical trial investigating its TrueBlue mental health app for women at various stages of pregnancy.
The trial, which is being conducted in partnership with the UK’s Institute of Mental Health, will establish the safety and efficacy of the app. It is slated to enrol 125 perinatal women through NHS hospitals and will begin in early 2024, lasting for 14 months, according to a 30 November press release.
BlueSkeye AI’s app uses artificial intelligence (AI) to scan the user’s face and analyse their voice to...
Today's Sponsors
Today's Sponsor